Mobio Interactive

Mobio Interactive has developed and commercialized an AI-native mobile digital diagnostic and psychotherapy platform for mental health. The platform uses proprietary deep neural networks and computer vision to provide objective, real-time biomarker-based assessment of psychological stress and brain states — moving beyond subjective self-reported questionnaires. It serves as a scalable stopgap for patients on healthcare waitlists and includes remote monitoring tools to facilitate personalized therapy based on objective measures of efficacy. The platform has been clinically validated in adults and adolescents across applications including anxiety, cancer, concussion, and pediatric populations, with peer-reviewed prospective real-world studies demonstrating its mechanism of action.